PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,321,211 | -7.6% | 3,151,699 | -2.9% | 20.74% | +20.7% |
| Q2 2023 | $56,642,176 | -29.1% | 3,247,317 | +8.2% | 17.19% | -18.9% |
| Q1 2023 | $79,848,812 | +30.3% | 3,001,835 | -6.2% | 21.20% | +29.8% |
| Q4 2022 | $61,303,262 | -13.9% | 3,199,892 | -6.2% | 16.33% | -14.7% |
| Q3 2022 | $71,230,000 | +186.2% | 3,409,758 | +9.8% | 19.15% | +101.5% |
| Q2 2022 | $24,886,000 | +33.6% | 3,106,807 | +16.9% | 9.50% | +20.0% |
| Q1 2022 | $18,629,000 | -46.3% | 2,657,457 | +3.4% | 7.92% | -31.2% |
| Q4 2021 | $34,688,000 | -17.3% | 2,569,479 | +3.4% | 11.51% | -6.0% |
| Q3 2021 | $41,942,000 | -39.2% | 2,484,724 | +4.9% | 12.24% | -23.7% |
| Q2 2021 | $68,953,000 | -24.6% | 2,367,888 | +1.9% | 16.04% | -12.4% |
| Q1 2021 | $91,434,000 | +70.9% | 2,324,795 | -1.3% | 18.30% | +21.5% |
| Q4 2020 | $53,501,000 | +0.4% | 2,354,799 | +0.1% | 15.07% | -20.5% |
| Q3 2020 | $53,279,000 | -28.8% | 2,352,291 | +2.0% | 18.95% | -35.1% |
| Q2 2020 | $74,853,000 | – | 2,305,994 | – | 29.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |